Isolation of Tissue Extracellular Vesicles from the Liver
August 21st, 2019
13.2K views
This is a protocol to isolate tissue extracellular vesicles (EVs) from the liver. The protocol describes a two-step process involving collagenase perfusion followed by differential ultracentrifugation to isolate liver tissue EVs.
Overview
This protocol outlines a method for isolating extracellular vesicles (EVs) from liver tissue using collagenase perfusion and differential ultracentrifugation. This approach provides a source of EVs that reflect the local tissue microenvironment, aiding in the study of their physiological roles and alterations in disease.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Extracellular Vesicle Research
Background
- Extracellular vesicles play crucial roles in intercellular communication.
- Understanding their function in vivo is essential for elucidating disease mechanisms.
- This protocol facilitates the study of EVs derived from liver tissue.
- Visual demonstrations of the procedure enhance reproducibility.
Purpose of Study
- To isolate liver-derived extracellular vesicles for research.
- To investigate the physiological roles of EVs in the tissue microenvironment.
- To provide a reliable method for studying EV alterations in disease.
Methods Used
- Collagenase perfusion to digest liver tissue.
- Differential ultracentrifugation to isolate EVs.
- Nanoparticle tracking analysis to characterize EV concentration and size.
- Visual demonstration of portal vein cannulation technique.
Main Results
- Yielded a concentration of 1.74 to 4 x 10^12 particles/mL of EVs.
- Mean size of isolated EVs was 157.7 nm, with a mode of 144.5 nm.
- Isolated EVs are suitable for downstream applications.
- Characterization can include morphological assessments and surface marker analysis.
Conclusions
- This protocol provides a robust method for isolating liver EVs.
- Isolated EVs can be used for various downstream analyses.
- Further studies can enhance understanding of EV roles in health and disease.
Frequently Asked Questions
What are extracellular vesicles?
Extracellular vesicles are membrane-bound particles released by cells that play roles in cell communication and signaling.
Why is liver tissue used for isolating EVs?
Liver tissue is rich in EVs that reflect the local microenvironment, making it ideal for studying their physiological roles.
What is the significance of the size of isolated EVs?
The size of EVs can influence their biological functions and interactions with other cells.
How can isolated EVs be characterized?
Isolated EVs can be characterized using techniques like nanoparticle tracking analysis and electron microscopy.
What downstream applications can isolated EVs be used for?
Isolated EVs can be used for studies on their content, surface markers, and roles in various biological processes.
What precautions should be taken during the procedure?
Care should be taken to avoid damaging internal organs during the surgical procedure and to maintain sterile conditions.
Executive Industry Relevance
Isolating extracellular vesicles from liver tissue enables direct study of in vivo vesicle populations that reflect the local microenvironment, supporting target validation and mechanistic de-risking in hepatology and metabolic disease research. This method provides a reproducible source of tissue-derived vesicles for biomarker discovery and preclinical model development, improving predictive confidence in early-stage therapeutic hypotheses. By yielding quantifiable EV concentrations and size profiles, the approach facilitates assay standardization and cross-functional collaboration in discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of tissue-specific EV roles in physiological and pathophysiological processes, supporting target hypothesis testing.
- Operational Value: Provides a consistent source of liver-derived EVs for functional assays that clarify pathway involvement and biological de-risking.
Screening & Assay Development
- Scientific Value: Yields EVs suitable for downstream characterization, enabling standardized assays for cargo analysis and surface marker profiling.
- Operational Value: Delivers reproducible nanoparticle tracking analysis outputs for concentration and size metrics, supporting assay readiness and scalability.
Translational & Preclinical Research
- Scientific Value: Connects in vivo EV isolation to disease-relevant systems, allowing study of EV alterations in pathophysiological contexts.
- Operational Value: Supports translational biomarker alignment by providing vesicles reflective of the liver microenvironment for preclinical validation.
Pipeline & Workflow Integration
The method integrates into discovery workflows by providing tissue-derived EVs that support hypothesis testing, assay development, and preclinical continuity, particularly in liver-focused therapeutic areas.
- Discovery Biology: Supports mechanistic de-risking by enabling study of EV-mediated communication in the liver tissue microenvironment.
- Screening: Produces standardized EV isolates with quantifiable concentration and size, facilitating reliable compound or modulator screening.
- Analytics: Generates nanoparticle tracking analysis data for concentration (1.74–4 × 10¹² particles/mL) and size (mean 157.7 nm), enabling comparative condition assessment.
- Translational Research: Links tissue EV profiles to disease models, supporting risk-adjusted advancement decisions in preclinical programs.
- Enterprise Reuse: Establishes a reusable collagenase perfusion and ultracentrifugation protocol for consistent EV isolation across liver studies.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by providing tissue-representative EVs that reduce mechanistic ambiguity in target validation.
- Operational Value: Ensures standardization and reproducibility through defined perfusion, digestion, and centrifugation steps.
- Strategic Value: Improves go/no-go decisions by enabling early assessment of EV-mediated biological activity in disease models.
- Portfolio Impact: Informs risk-adjusted prioritization through quantitative EV yield and characterization data from tissue sources.
Implementation Considerations
- Requires expertise in rodent surgery, vascular cannulation, and aseptic tissue handling.
- Dependent on perfusion pumps, centrifuges, and nanoparticle tracking analyzers for execution and validation.
- Necessitates cross-team standardization of collagenase concentration, flow rates, and g-force parameters for reproducibility.
- Involves adaptation considerations when applying the protocol to other tissues with differing structural integrity.
- Limited by tissue dissociation challenges that may affect EV yield if collagenase digestion is suboptimal.
Biopharma FAQs
Why does nanoparticle tracking analysis matter for EV yield quantification?
Nanoparticle tracking analysis provides quantitative measurements of extracellular vesicle concentration and size distribution, which are essential for assessing yield consistency and enabling reproducible downstream applications in biomarker studies.
How does collagenase perfusion improve EV isolation from liver tissue?
Collagenase perfusion enables efficient tissue dissociation without mechanical damage, increasing extracellular vesicle yield compared to homogenization by preserving vesicle integrity during liver digestion.
What does supernatant centrifugation remove before ultracentrifugation?
Sequential centrifugation steps remove hepatocytes, dead cells, and cellular debris from the supernatant, reducing contamination and enriching for extracellular vesicles prior to ultracentrifugation.
Why is EV size characterization important for downstream applications?
Size characterization via nanoparticle tracking analysis informs on vesicle heterogeneity and helps predict biological function, as extracellular vesicle size ranges from 100 to 600 nanometers influence cellular uptake and cargo delivery.
What statistical analysis is required to validate EV isolation reproducibility?
Reproducibility requires statistical comparison of nanoparticle tracking analysis results across runs, including concentration (1.74–4 × 10¹² particles/mL) and modal size (144.5 nm), to confirm consistent isolation performance before implementation in screening pipelines.
